Literature DB >> 10867507

Induction of apoptosis in bronchial eosinophils: beneficial or harmful?

N Yamashita1, M Tajima, J Nakano, H Arioka, H Arai, T Miyasaka, S Kubota, R Kawashima, K Ohta.   

Abstract

BACKGROUND: Prominent eosinophil infiltration takes place in asthmatic bronchi, and damages bronchial epithelial cells. AIM: This study was designed to investigate whether induction of apoptosis in infiltrated cells in the airways is beneficial or harmful.
METHODS: A/J mice, which are genetically predisposed to be hyperresponsive to acetylcholine, were immunized with ovalbumin (OA) and alum. Thereafter, they were subjected to a 2-week regimen of OA inhalation, during which they were also administered either hamster anti-mouse Fas monoclonal antibody or hamster IgG (sham control) intranasally. Pulmonary function was then analyzed using whole-body plethysmography.
RESULTS: Inhalation of OA increased both airway responsiveness to acetylcholine and infiltration of eosinophils. Administration of anti-Fas antibody induced apoptosis in the infiltrating eosinophils and abolished the increase in airway responsiveness to acetylcholine.
CONCLUSION: Induction of apoptosis in eosinophils infiltrating asthmatic bronchi has a beneficial effect on airway hyperresponsiveness. Copyright 2000 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10867507     DOI: 10.1159/000053631

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  2 in total

1.  Brucella abortus invasion of osteoblasts inhibits bone formation.

Authors:  Romina Scian; Paula Barrionuevo; Carlos A Fossati; Guillermo H Giambartolomei; M Victoria Delpino
Journal:  Infect Immun       Date:  2012-04-30       Impact factor: 3.441

2.  Demographic and clinical characteristics of patients with anaphylactic shock after surgery for cystic echinococcosis.

Authors:  Yimei Li; Hong Zheng; Xinghua Cao; Zaoling Liu; Lili Chen
Journal:  Am J Trop Med Hyg       Date:  2011-09       Impact factor: 2.345

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.